IBRX vs PGR · rev $113.3M vs P/E 10, rev $87.67B
Immunitybio Inc (IBRX) versus Progressive Corp (PGR) — a side-by-side from cached financials, not a winner call.
Immunitybio Inc (IBRX) is a biotechnology company listed on US.
Progressive Corp (PGR) is a insurance - property & casualty company listed on NYSE.
Latest reported IBRX revenue for 2025-12-31 was $113.3M. Net income was -$351.4M. Revenue was up 668.3% from 2024-12-31 to 2025-12-31. IBRX currently screens at market cap $7.88B.
Latest reported PGR revenue for 2025-12-31 was $87.67B. Net income was $11.31B. Revenue was up 16.3% from 2024-12-31 to 2025-12-31. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
IBRX currently screens at market cap $7.88B. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
Not investment advice. Open the IBRX and PGR stock pages for the full models.
Not investment advice.